Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The intrauterine contraceptive device is a popular form of contraception for women; however, it does carry a rare but serious risk of migration into the myometrium and then into the peritoneal cavity. We report an unusual case of an intrauterine contraceptive device (IUCD) migrating through the uterus into the peritoneal cavity and subsequently into the sigmoid colon, which was finally retrieved laparoscopically. We also discuss three different methods for the retrieval of a migrated IUCD: colonoscopy, hysteroscopy and laparoscopy and compare and contrast each method.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813589 | PMC |
| http://dx.doi.org/10.1093/jscr/rjt072 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Virtual Reality for Analgesia During Intrauterine Device Insertion: Randomized Controlled Trial.
JMIR Serious Games
September 2025
Women's and Newborn Program, Monash Health, 246 Clayton Rd, Melbourne, 3168, Australia, 61 395946666.
Background: Intrauterine devices (IUDs) are safe and effective long-acting reversible contraceptive therapies that are also used as minimally invasive treatment for heavy menstrual bleeding, endometrial hyperplasia, and early-stage endometrial cancer. Despite many advantages, IUDs are underused predominantly due to patient discomfort. Although many techniques have been explored previously in the literature, there is currently little consensus on effective analgesic strategies.
View Article and Find Full Text PDFSafety and effectiveness of contraception among women with chronic kidney disease: a systematic review.
Contraception
September 2025
Division of Reproductive Health, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA, United States, 30341.
Objectives: To systematically review evidence on the safety and effectiveness of contraceptive use among women with chronic kidney disease (CKD).
Study Design: We searched for articles in multiple databases from database inception through December 12, 2022, that assessed safety and effectiveness of contraceptive use among women with CKD; all study designs were included. We extracted data from included articles; for studies that were not case series or case reports, we assessed risk of bias and determined certainty of evidence for each outcome.
Cesarean Delivery Scar Ectopic Pregnancy Diagnosed after No-Test Abortion: A Case Report.
Contraception
September 2025
University of Maryland School of Medicine, 11 S Paca Street, Suite 400, Baltimore MD 21201.
We present a case of cesarean scar ectopic pregnancy that was diagnosed after failed no-test medication abortion at 4 weeks gestation. The patient was treated with dilation, suction aspiration and intrauterine Foley balloon placement. No adverse outcome occurred.
View Article and Find Full Text PDFReal-world validation of a bleeding prediction algorithm in levonorgestrel intrauterine device users using the MyIUS mobile app.
Contraception
September 2025
Bayer Aktiengesellschaft, Wuppertal - Aprath, Germany.
Objective: This study aimed to validate the real-world performance of the MyIUS mobile-application algorithm in predicting bleeding intensity and regularity in levonorgestrel intrauterine device (LNG-IUD) 52 mg, 19.5 mg, and 13.5 mg users following device insertion.
View Article and Find Full Text PDFThe impact of hormonal intrauterine device use on health-related quality of life in women with a history of venous thromboembolism: a systematic review.
Eur J Contracept Reprod Health Care
September 2025
Federal University of Minas Gerais, Belo Horizonte, Brazil.
Objective: To systematically review the available evidence on changes in health-related quality of life (HRQoL) associated with the levonorgestrel-releasing intrauterine system (LNG-IUS) for contraception or menstrual bleeding management in women with a history of venous thromboembolism (VTE), regardless of anticoagulant use.
Methods: This systematic review was conducted following Cochrane Collaboration guidelines and the PRISMA statement. A comprehensive search was carried out in PubMed, Embase, Cochrane Central, Scopus, Web of Science, and the Virtual Health Library (VHL), without language or date restrictions.